It has been shown that miR‐485‐5p overexpression decreased breast tumour development and promoted chemosensitivity partly via modulating survivin expression.35 Previous study indicated that miR‐485‐5p expression was down‐regulated in the serum of NSCLC cells and patients. The gene discussed is BIRC5; the disease is non-small cell lung carcinoma.